Actionable news
0
All posts from Actionable news
Actionable news in KBIO: KaloBios Pharmaceuticals, Inc.,

Kalobios Pharmaceuticals, Inc. Announces Management Changes

The following excerpt is from the company's SEC filing.

SOUTH SAN FRANCISCO, Calif., Dec. 21, 2015 /PRNewswire/ -- KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO), today announced that on December 17, 2015, Martin Shkreli was terminated as Chief Executive Officer of the Company and resigned from his position as a member of the board of directors. In addition, on December 17, 2015, Tony Chase resigned from his position as a member of the board of directors.

Forward-Looking Statements

This release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current knowledge, assumptions, judgment and expectations regarding future performance or events. Although management believes that the expectations reflected in such statements are reasonable, they give no assurance that such expectations will prove to be correct and you should be aware that actual results could differ materially from those contained in the forward-looking...


More